Trial confirms heart benefits of Wegovy, but is weight loss responsible – or something else?
By Meg Tirrell, CNN (CNN) — Results from a landmark clinical trial this summer suggested, for the first time, that a medication given for weight loss alone could reduce the risk of heart attack, stroke or heart-related death in people with cardiovascular disease, bolstering physicians’ excitement about an already-exploding class of new medicines. Novo Nordisk’s
Continue Reading